BSX vs MDT
BSX and MDT side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | MDTMedtronic plc |
|---|---|---|
| Market cap | $63.62B | $126.53B |
| P/E (TTM) | 17.8 | 24.4 |
| P/B | 2.55 | 2.52 |
| P/S | 3.1x | 3.4x |
| Dividend yield | — | 2.88% |
| Revenue | $21.00B(TTM) | $37.54B(TTM) |
| Revenue growth (YoY) | 19.9% | 8.4% |
| Net income | $3.67B(TTM) | $430.00M(TTM) |
| Earnings growth (YoY) | 56.7% | 3.0% |
| EPS, diluted | $2.47(TTM) | $4.06(TTM) |
| EBIT margin | 18.0% | 17.8% |
| ROE | 11.6% | 0.0% |
| ROIC | 10.0% | 7.0% |
| Piotroski F | 8/9 | 8/9 |
| 1y total return | -56.8% | +10.7% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: BSX frente a MDT
| Métrica | BSX | MDT |
|---|---|---|
| Valor final | $18.8K | $14.7K |
| Retorno total | +88.0% | +47.0% |
| CAGR | +6.3% | +3.8% |
| Volatilidad | 27.6% | 23.4% |
| Sharpe | 0.21 | 0.10 |
| Sortino | 0.28 | 0.14 |
| Caída máxima | -61.5% | -45.3% |
Basado en 2600 días de negociación comunes, 2016-06-30 → 2026-11-02 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)